Yousif Capital Management LLC Has $3.78 Million Stake in Tenet Healthcare Co. (NYSE:THC)

Yousif Capital Management LLC lessened its position in Tenet Healthcare Co. (NYSE:THC) by 4.1% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 29,914 shares of the company’s stock after selling 1,279 shares during the quarter. Yousif Capital Management LLC’s holdings in Tenet Healthcare were worth $3,776,000 as of its most recent filing with the SEC.

A number of other large investors have also recently bought and sold shares of the company. Plato Investment Management Ltd bought a new position in Tenet Healthcare in the third quarter valued at $28,000. ORG Wealth Partners LLC bought a new position in shares of Tenet Healthcare in the 3rd quarter valued at about $30,000. Financial Management Professionals Inc. raised its holdings in Tenet Healthcare by 2,222.2% during the third quarter. Financial Management Professionals Inc. now owns 209 shares of the company’s stock worth $35,000 after acquiring an additional 200 shares in the last quarter. True Wealth Design LLC bought a new position in Tenet Healthcare in the third quarter valued at approximately $38,000. Finally, Hantz Financial Services Inc. bought a new stake in shares of Tenet Healthcare during the 3rd quarter worth approximately $83,000. Institutional investors and hedge funds own 95.44% of the company’s stock.

Tenet Healthcare Stock Up 0.6 %

NYSE THC opened at $140.63 on Friday. The company has a 50 day moving average of $133.96 and a 200-day moving average of $148.59. Tenet Healthcare Co. has a 1-year low of $86.70 and a 1-year high of $171.20. The company has a current ratio of 1.58, a quick ratio of 1.52 and a debt-to-equity ratio of 2.35. The company has a market cap of $13.37 billion, a price-to-earnings ratio of 4.51, a PEG ratio of 0.63 and a beta of 2.05.

Wall Street Analysts Forecast Growth

THC has been the topic of several analyst reports. Barclays upped their price target on shares of Tenet Healthcare from $171.00 to $190.00 and gave the stock an “overweight” rating in a research report on Friday, November 8th. JPMorgan Chase & Co. reiterated an “overweight” rating and set a $175.00 price target on shares of Tenet Healthcare in a report on Tuesday, December 17th. Raymond James cut Tenet Healthcare from a “strong-buy” rating to an “outperform” rating and set a $195.00 price objective for the company. in a research report on Friday, November 22nd. StockNews.com cut Tenet Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, December 17th. Finally, Cantor Fitzgerald upped their price objective on shares of Tenet Healthcare from $168.00 to $177.00 and gave the company an “overweight” rating in a report on Wednesday, October 30th. Three analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $165.00.

Tenet Healthcare Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.